According to the latest report by IMARC Group, titled “Anti-obesity Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, offers a comprehensive analysis of the industry, which comprises insights on the global anti-obesity drugs market. The report also includes competitor and regional analysis, and contemporary advancements in the market.
Anti-obesity Drugs Market Overview:
The global anti-obesity drugs market size reached a value of US$ 1.78 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 3.63 Billion by 2027, exhibiting a CAGR of 12.20% during 2022-2027.
Anti-obesity drugs are used to reduce weight and are usually medically prescribed only in cases of morbid obesity. They aid in decreasing cravings and controlling compulsive eating, particularly for sweets and fatty, salty and high-calorie food products. They also offer independent health benefits, such as maintaining waist circumference, blood pressure, harmful lipid levels, non-alcoholic fatty liver disease (NAFLD), sugar levels; diminishing the risk of major cardiovascular diseases; and the development of diabetic kidney disease.
Request a PDF Sample Copy for more detailed market insights: https://www.imarcgroup.com/anti-obesity-drugs-market/requestsample
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Anti-Obesity Drugs Market Trends and Drivers:
One of the primary factors driving the market is the extensive prevalence of obesity due to sedentary lifestyles. In confluence with this, the latest advancements in the anti-obesity drugs have enabled the capability of accomplishing clinically significant weight loss among individuals as obesity increases the risk of causing type 2 diabetes (T2D), cancer of esophagus, colons and rectums, liver, gallbladder, pancreas and kidney.
Besides this, it also results in various neurological, psychological, gastrointestinal, renal, pulmonary and endocrine diseases. Furthermore, sleep deprivation, circadian desynchronization, chronic stress and the increasing usage of photopic and epileptic drugs result in increased weight gain.
Along with this, the escalating number of approvals of anti-obesity medications (AOM) that aid in regulating appetite and food cravings is propelling the market growth. In line with this, weight loss assists in enhancing the quality of life, daily function mobility and psychological well-being.
Moreover, the rising health consciousness, increasing focus on the management of diseases closely integrated with excess body weight and expanding pharmaceutical industry are some of the other factors creating a positive market outlook.
Explore Full Report with TOC & List of Figures: https://www.imarcgroup.com/anti-obesity-drugs-market
Important Note: If the link is not clickable please open it in a new tab, you will get detailed analysis of the market, growth analysis graphs, historical period analysis, forecast period analysis, major market segmentation, top leading key players of the market, table of content, list of figures, and list of tables.
Global Anti-Obesity Drugs Market 2022-2027 Analysis and Segmentation:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
- Binderholz GmbH
- Dongwha Enterprise
- EGGER Group
- Evergreen Fibreboard Berhad
- Georgia-Pacific LLC (Koch Industries Inc.)
- Green River Holding Co. Ltd.
- Kastamonu Entegre
- Louisiana-Pacific Corporation
- Sonae Arauco
- Starbank Panel Products Ltd.
- West Fraser Timber Co. Ltd.
- Weyerhaeuser Company
The report has segmented the market on the basis of region, drug class, drug type and distribution channel.
Breakup by Drug Class:
- Peripherally Acting Drugs
- Centrally Acting Drugs
Breakup by Drug Type:
- Prescription Drugs
- OTC Drugs
Market Breakup by Distribution Channel:
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022- 2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800